NCT03004183 2024-10-15
STOMP
The Methodist Hospital Research Institute
Phase 2 Completed
Clinical Trials
9 trialsNCT00589875 2024-04-03
BrTK02
Candel Therapeutics, Inc.
Phase 2 Completed
NCT00638612 2023-08-25
PaTK01
Candel Therapeutics, Inc.
Phase 1 Completed
NCT00751270 2023-08-25
BrTK01
Candel Therapeutics, Inc.
Phase 1 Completed
NCT01997190 2023-08-25
MpeTK01
Candel Therapeutics, Inc.
Phase 1 Completed
NCT01972035 2022-04-12
ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
University of Minnesota
Phase 2 Completed
NCT00042328 2015-08-24
A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology Patients
Baylor College of Medicine
Phase 2 Completed
NCT00562770 2012-07-31
Oral Valganciclovir Versus Valacyclovir
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00274404 2011-10-27
Controlled Trial of Valacyclovir in Infectious Mononucleosis
University of Minnesota
Phase 1/2 Completed